PRAC meeting highlights 04 - 07 May 2026

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the May meeting are now available on the EMA website